share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Reents Scott T

SEC announcement ·  Mar 2 06:55
Summary by Futu AI
Scott T Reents, EVP and Chief Financial Officer of AbbVie Inc. (ABBV), completed a series of transactions involving the company's common stock. On February 23, 2024, Reents acquired 14,140 shares at $61.36 per share through the exercise of derivative securities. On the same day, he sold the same number of shares at $177.44, followed by another sale of 11,634 shares on February 28, 2024, at $178.99 per share. These sales resulted in a total market value of $4,591,371.26. After these transactions, Reents directly holds 15,431 shares of AbbVie common stock.
Scott T Reents, EVP and Chief Financial Officer of AbbVie Inc. (ABBV), completed a series of transactions involving the company's common stock. On February 23, 2024, Reents acquired 14,140 shares at $61.36 per share through the exercise of derivative securities. On the same day, he sold the same number of shares at $177.44, followed by another sale of 11,634 shares on February 28, 2024, at $178.99 per share. These sales resulted in a total market value of $4,591,371.26. After these transactions, Reents directly holds 15,431 shares of AbbVie common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.